Retatrutide to Tirzepatide Switch

TRANSITIONING FROM RETATRUTIDE TO TIRZEPATIDE

IMPORTANT DISCLAIMER

There is currently very limited clinical guidance regarding transitioning from Retatrutide to Tirzepatide.

This page is based on educational discussions, pharmacologic reasoning, and community-reported experiences. This is NOT medical advice.

Always consult a qualified healthcare professional before transitioning between compounds.

━━━━━━━━━━━━━━━━━━
WHY SOME PEOPLE SWITCH BACK
━━━━━━━━━━━━━━━━━━

Some users transition from Retatrutide back to Tirzepatide due to:

• Strong Retatrutide side effects
• Excessive appetite suppression
• Increased body heat or thermogenic effects
• GI intolerance
• Cost or availability concerns
• Preference for Tirzepatide tolerability
• Entering a maintenance phase

━━━━━━━━━━━━━━━━━━
IMPORTANT THINGS TO KNOW
━━━━━━━━━━━━━━━━━━

Retatrutide differs from Tirzepatide because it activates:
• GLP-1 receptor
• GIP receptor
• Glucagon receptor

Tirzepatide only activates:
• GLP-1 receptor
• GIP receptor

Because Retatrutide includes glucagon receptor activity, some users report:
• stronger metabolic effects
• more body heat
• stronger appetite suppression
• stronger side effects overall

Transitioning back to Tirzepatide may feel less intense metabolically for some individuals.

━━━━━━━━━━━━━━━━━━
COMMON COMMUNITY APPROACH
━━━━━━━━━━━━━━━━━━

STEP 1
Take your final Retatrutide dose on your normal schedule.

STEP 2
Wait approximately 1-2 weeks before starting Tirzepatide.

This allows Retatrutide levels to decrease before introducing another GLP-1/GIP agonist.

STEP 3
Restart Tirzepatide conservatively.

Even if previously tolerated well, many users prefer restarting at:
• 2.5mg
• 5mg

before gradually titrating upward again depending on tolerance and goals.

━━━━━━━━━━━━━━━━━━
EXAMPLE TRANSITION TIMELINE
━━━━━━━━━━━━━━━━━━

Week 0
• Final Retatrutide dose

Week 1
• Washout period
• No injection

Week 2
• Begin Tirzepatide 2.5mg or 5mg weekly

Weeks 3-5
• Continue current Tirzepatide dose
• Assess hunger, side effects, and appetite control

Week 6+
• Gradually titrate upward if needed and tolerated

━━━━━━━━━━━━━━━━━━
WHAT TO EXPECT
━━━━━━━━━━━━━━━━━━

WASHOUT PERIOD
• Appetite may temporarily increase
• Food noise may return
• Mild weight fluctuations may occur

EARLY TIRZEPATIDE PHASE
• Appetite suppression gradually returns
• Tirzepatide may feel “milder” compared to Retatrutide initially
• GI symptoms may still occur during transition

LATER TITRATION PHASE
• Appetite control stabilizes
• Many users report improved tolerability compared to Retatrutide
• Metabolic intensity may feel lower due to absence of glucagon receptor activation

━━━━━━━━━━━━━━━━━━
COMMON MISTAKES
━━━━━━━━━━━━━━━━━━

• Starting Tirzepatide too aggressively
• Overlapping high-dose Retatrutide and Tirzepatide
• Ignoring rebound hunger during washout
• Increasing Tirzepatide too rapidly
• Failing to monitor side effects and appetite changes

━━━━━━━━━━━━━━━━━━
IMPORTANT NOTES
━━━━━━━━━━━━━━━━━━

• There is NO official dose conversion between Retatrutide and Tirzepatide
• Individual response varies significantly
• Appetite and metabolic effects may differ substantially between compounds
• Proper nutrition, hydration, sleep, and exercise remain important during transition

━━━━━━━━━━━━━━━━━━
DISCLAIMER
━━━━━━━━━━━━━━━━━━

This page is provided for educational and informational purposes only.

Bonita does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before transitioning between compounds or starting any peptide protocol.